Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia

Neurobiology of Disease

Volumn 65, Issue , 2014, Pages 124-132

  Martella, G ^a,b   Maltese, M ^a   Nistico R ^b,c   Schirinzi, T ^a   Madeo, G ^a   Sciamanna, G ^a,b   Ponterio, G ^a,b   Tassone, A ^b   Mandolesi, G ^a,b   Vanni, V ^b   Pignatelli, M ^c   Bonsi, P ^b   Pisani, A ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cholinergic interneurons; D2 dopamine receptor; Dystonia; Long term depression; Long term potentiation; Muscarinic receptor antagonists; Striatum

Indexed keywords

CHOLINERGIC INTERNEURONS; D2 DOPAMINE RECEPTOR; DYSTONIA; LONG-TERM DEPRESSION; LONG-TERM POTENTIATION; MUSCARINIC RECEPTOR ANTAGONISTS; STRIATUM;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GABA ANTAGONISTS; GENE EXPRESSION REGULATION; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; MUSCARINIC ANTAGONISTS; MUTATION; NEURONAL PLASTICITY; NEURONS; PICROTOXIN; PIRENZEPINE; SYNAPSES;

EID: 84894044685     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.01.016     Document Type: Article

References (36)

1. Albanese A., Bhatia K., Bressman S., Delong M.R., Fahn S., Fung V.S., Hallett M., Jankovic J., Jinnah H.A., Klein C., Lang A.E., Mink J.W., Teller J.K. Phenomenology and classification of dystonia: a consensus update. Mov. Disord. 2013, 28:863-873.
2. Blokland A. Acetylcholine: a neurotransmitter for learning and memory?. Brain Res. Rev. 1996, 21:285-300.
3. Bonsi P., Martella G., Cuomo D., Platania P., Sciamanna G., Bernardi G., Wess J., Pisani A. Loss of muscarinic autoreceptor function impairs long-term depression, but not long-term potentiation in the striatum. J. Neurosci. 2008, 28:6258-6263.
4. Bostan A.C., Dum R.P., Strick P.L. The basal ganglia communicate with the cerebellum. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:8452-8456.
5. Breakefield X.O., Blood A.J., Li Y., Hallett M., Hanson P.I., Standaert D.G. The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 2008, 9:222-234.
6. Calabresi P., Maj R., Pisani A., Mercuri N.B., Bernardi G. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J. Neurosci. 1992, 12:4224-4233.
7. Carbon M., Niethammer M., Peng S., Raymond D., Dhawan V., Chaly T., Ma Y., Bressman S., Eidelberg D. Abnormal striatal and thalamic dopamine neurotransmission: genotype-related features of dystonia. Neurology 2009, 72:2097-2103.
8. Centonze D., Usiello A., Costa C., Picconi B., Erbs E., Bernardi G., Borrelli E., Calabresi P. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. J. Neurosci. 2004, 24:8214-8222.
9. Crepel F., Dhanjal S.S. Cholinergic mechanisms and neurotransmission in the cerebellum of the rat. An in vitro study. Brain Res. 1982, 244:59-68.
10. Dang M.T., Yokoi F., Cheetham C.C., Lu J., Vo V., Lovinger D., Li Y. An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 δGAG knock-in mice. Behav. Brain Res. 2012, 226:465-472.
11. Edwards M.J., Huang Y.Z., Mir P., Rothwell J.C., Bhatia K.P. Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Mov. Disord. 2006, 21:2181-2186.
12. Fuchs T., Saunders-Pullman R., Masuho I., Luciano M.S., Raymond D., Factor S., Lang A.E., Liang T.W., Trosch R.M., White S., Ainehsazan E., Hervé D., Sharma N., Ehrlich M.E., Martemyanov K.A., Bressman S.B., Ozelius L.J. Mutations in GNAL cause primary torsion dystonia. Nat. Genet. 2013, 45:88-92.
13. Ghilardi M.F., Carbon M., Silvestri G., Dhawan V., Tagliati M., Bressman S., Ghez C., Eidelberg D. Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann. Neurol. 2003, 54:102-109.
14. Goodchild R.E., Kim C.E., Dauer W.T. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005, 48:923-932.
15. Granata A., Warner T.T. The role of torsinA in dystonia. Eur. J. Neurol. 2010, 17(Suppl. 1):81-87.
16. Grundmann K., Glöckle N., Martella G., Sciamanna G., Hauser T.K., Yu L., Castaneda S., Pichler B., Fehrenbacher B., Schaller M., Nuscher B., Haass C., Hettich J., Yue Z., Nguyen H.P., Pisani A., Riess O., Ott T. Generation of a novel rodent model for DYT1 dystonia. Neurobiol. Dis. 2012, 47:61-74.
17. Jankovic J. Treatment of dystonia. Lancet Neurol. 2006, 5:864-872.
18. Lehéricy S., Tijssen M.A., Vidailhet M., Kaji R., Meunier S. The anatomical basis of dystonia: current view using neuroimaging. Mov. Disord. 2013, 28:944-957.
19. Martella G., Tassone A., Sciamanna G., Platania P., Cuomo D., Viscomi M.T., Bonsi P., Cacci E., Biagioni S., Usiello A., Bernardi G., Sharma N., Standaert D.G., Pisani A. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 2009, 132:2336-2349.
20. Napolitano F., Pasqualetti M., Usiello A., Santini E., Pacini G., Sciamanna G., Errico F., Tassone A., Di Dato V., Martella G., Cuomo D., Fisone G., Bernardi G., Mandolesi G., Mercuri N.B., Standaert D.G., Pisani A. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Neurobiol. Dis. 2010, 38:434-445.
21. Neychev V.K., Gross R.E., Lehéricy S., Hess E.J., Jinnah H.A. The functional neuroanatomy of dystonia. Neurobiol. Dis. 2011, 42:185-201.
22. Nisticò R., Mango D., Mandolesi G., Piccinin S., Berretta N., Pignatelli M., Religioni M., Musella A., Gentile A., Mori F., Bernardi G., Nicoletti F., Mercuri N.B., Centone D. Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. PLoS One 2013, 8:e54666.
23. Oleas J., Yokoi F., Deandrade M.P., Pisani A., Li Y. Engineering animal models of dystonia. Mov. Disord. 2013, 28:990-1000.
24. Ozelius L.J., Hewett J.W., Page C.E., Bressman S.B., Kramer P.L., Shalish C., de Leon D., Brin M.F., Raymond D., Corey D.P., Fahn S., Risch N.J., Buckler A.J., Gusella J.F., Breakefield X.O. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 1997, 17:40-48.
25. Perlmutter J.S., Mink J.W. Dysfunction of dopaminergic pathways in dystonia. Adv. Neurol. 2004, 94:163-170.
26. Pisani A., Ross W.N. Weak effect of neuromodulators on climbing fiber-activated [Ca(2+)](i) increases in rat cerebellar Purkinje neurons. Brain Res. 1999, 831:113-118.
27. Ponterio G., Tassone A., Sciamanna G., Riahi E., Vanni V., Bonsi P., Pisani A. Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum. Neuropharmacology 2013, 75C:78-85.
28. Sciamanna G., Tassone A., Martella G., Mandolesi G., Puglisi F., Cuomo D., Madeo G., Ponterio G., Standaert D.G., Bonsi P., Pisani A. Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia. PLoS One 2011, 6:e24261.
29. Sciamanna G., Hollis R., Ball C., Martella G., Tassone A., Marshall A., Parsons D., Li X., Yokoi F., Zhang L., Li Y., Pisani A., Standaert D.G. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA. Neurobiol. Dis. 2012, 47:416-427.
30. Shinoe T., Matsui M., Taketo M.M., Manabe T. Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus. J. Neurosci. 2005, 25:11194-11200.
31. Soares J.C., Oliveira M.G., Ferreira T.L. Inactivation of muscarinic receptors impairs place and response learning: implications for multiple memory systems. Neuropharmacology 2013, 73:320-326.
32. Song C.H., Bernhard D., Bolarinwa C., Hess E.J., Smith Y., Jinnah H.A. Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia. Neurobiol. Dis. 2013, 54:62-71.
33. Tanabe L.M., Martin C., Dauer W.T. Genetic background modulates the phenotype of a mouse model of DYT1 dystonia. PLoS One 2012, 7:e32245.
34. Wichmann T. Commentary: Dopaminergic dysfunction in DYT1 dystonia. Exp. Neurol. 2008, 212:242-246.
35. Yokoi F., Dang M.T., Miller C.A., Marshall A.G., Campbell S.L., Sweatt J.D., Li Y. Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice. Neurosci. Res. 2009, 5:228-235.
36. Yokoi F., Cheetham C.C., Campbell S.L., Sweatt J.D., Li Y. Pre-synaptic release deficits in a DYT1 dystonia mouse model. PLoS One 2013, 8:e72491.